Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-013954
Filing Date
2023-02-28
Accepted
2023-02-28 21:52:00
Documents
2
Period of Report
2023-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5495
2 POA DOCUMENT poa.txt EX-24 4388
  Complete submission text file 0001209191-23-013954.txt   11359
Mailing Address C/O UCSF, 1450 3RD STREET RM HD-371 SAN FRANCISCO CA 941439001
Business Address
MCCORMICK FRANK (Reporting) CIK: 0001257809 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 23689520

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations